ViroGates A/S (VIRO.CO)

DKK 7.0

(1.74%)

Operating Expenses Summary of ViroGates A/S

ViroGates A/S's latest annual operating expenses in 2023 was 18.37 Million DKK , down -27.98% from previous year.
ViroGates A/S's latest quarterly operating expenses in 2024 Q2 was 4.67 Million DKK , up 1.99% from previous quarter.
ViroGates A/S reported a annual operating expenses of 23.5 Million DKK in annual operating expenses 2022, down -4.38% from previous year.
ViroGates A/S reported a annual operating expenses of 24.57 Million DKK in annual operating expenses 2021, up 2.75% from previous year.
ViroGates A/S reported a quarterly operating expenses of 4.57 Million DKK for 2024 Q1, up 22.63% from previous quarter.
ViroGates A/S reported a quarterly operating expenses of 16.92 Million DKK for 2023 FY, down -27.98% from previous quarter.

Annual Operating Expenses Chart of ViroGates A/S (2023 - 2015)

Historical Annual Operating Expenses of ViroGates A/S (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	18.37 Million DKK	-27.98%
2022	23.5 Million DKK	-4.38%
2021	24.57 Million DKK	2.75%
2020	23.91 Million DKK	4.35%
2019	22.92 Million DKK	8.6%
2018	21.1 Million DKK	114.01%
2017	9.86 Million DKK	-3.94%
2016	10.26 Million DKK	182.45%
2015	3.63 Million DKK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	4.67 Million DKK	1.99%
2024 Q1	4.57 Million DKK	22.63%
2023 FY	16.92 Million DKK	-27.98%
2023 Q3	4.41 Million DKK	-14.63%
2023 Q1	4.16 Million DKK	-51.3%
2023 Q2	5.17 Million DKK	24.27%
2023 Q4	3.73 Million DKK	-15.5%
2022 Q1	5.81 Million DKK	-6.22%
2022 FY	23.5 Million DKK	-4.38%
2022 Q4	8.55 Million DKK	89.12%
2022 Q3	4.52 Million DKK	-1.85%
2022 Q2	4.6 Million DKK	-20.83%
2021 Q2	6.7 Million DKK	7.73%
2021 Q1	6.22 Million DKK	-4.92%
2021 FY	24.57 Million DKK	2.75%
2021 Q4	6.2 Million DKK	13.98%
2021 Q3	5.44 Million DKK	-18.79%
2020 Q3	5.5 Million DKK	7.06%
2020 Q1	6.73 Million DKK	-8.58%
2020 Q4	6.54 Million DKK	18.94%
2020 Q2	5.14 Million DKK	-23.64%
2020 FY	23.91 Million DKK	4.35%
2019 Q2	5.97 Million DKK	22.56%
2019 FY	22.92 Million DKK	8.6%
2019 Q4	7.36 Million DKK	56.66%
2019 Q3	4.69 Million DKK	-21.4%
2019 Q1	4.87 Million DKK	-46.29%
2018 Q4	9.08 Million DKK	154.86%
2018 Q3	3.56 Million DKK	-31.46%
2018 Q1	3.25 Million DKK	49.29%
2018 Q2	5.2 Million DKK	59.66%
2018 FY	21.1 Million DKK	114.01%
2017 Q1	2.41 Million DKK	0.0%
2017 Q3	2.31 Million DKK	-21.62%
2017 Q2	2.95 Million DKK	22.01%
2017 FY	9.86 Million DKK	-3.94%
2017 Q4	2.18 Million DKK	-5.65%
2016 FY	10.26 Million DKK	182.45%
2015 FY	3.63 Million DKK	0.0%

Peer Operating Expenses Comparison of ViroGates A/S

Name	Operating Expenses	Operating Expenses Difference
Ambu A/S	2.31 Billion DKK	99.208%
ChemoMetec A/S	188.81 Million DKK	90.271%
Demant A/S	12.39 Billion DKK	99.852%
GN Store Nord A/S	8.16 Billion DKK	99.775%
Scandinavian Medical Solutions A/S	18.1 Million DKK	-1.477%